INmune Bio INMB

$ 4.77 4.61%

Quarterly report 2024-Q3
added 10-31-2024

INmune Bio Financial Statements 2011-2024 | INMB

Annual Financial Statements INmune Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	211 M	166 M	163 M	236 M	49.1 M	-	-	-	-	-	-	-	-
Shares	18 M	17.9 M	16.1 M	12.9 M	10.3 M	-	-	-	-	-	-	-	-
Historical Prices	11.8	9.25	10.1	18.2	4.93	-	-	-	-	-	-	-	-
Net Income	-30 M	-27.3 M	-30.3 M	-12.1 M	-7.68 M	-12.4 M	-831 K	-277 K	-	-	-	-	-
Revenue	155 K	374 K	181 K	10.9 K	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-10.9 K	-	-	-	-	-	-	-	-	-
Operating Income	-29.7 M	-26 M	-29.2 M	-12.2 M	-7.76 M	-12.4 M	-981 K	-	-	-	-	-	-
Interest Expense	2.28 M	2.01 M	-	129 K	77.7 K	-	150 K	-	-	-	-	-	-
EBITDA	-29.7 M	-26 M	-29.2 M	-12.2 M	-10.8 M	-12.4 M	-1.13 M	-177 K	-	-	-	-	-
Operating Expenses	29.9 M	26.3 M	29.3 M	12.2 M	9.3 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	9.62 M	9.26 M	8.79 M	6.32 M	6.02 M	11.3 M	546 K	126 K	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement INmune Bio

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	20.2 M	19.3 M	18 M	18 M	17.9 M	17.9 M	17.9 M	17.9 M	17.9 M	17.9 M	17.8 M	17.3 M	15 M	14.3 M	13.5 M	12.9 M	10.8 M	10.7 M	10.8 M	10.8 M	10.2 M	9.39 M	8.72 M	8.72 M	8.72 M	8.55 M	8.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-12.1 M	-9.75 M	-	-8.56 M	-6.5 M	-6.54 M	-	-7.72 M	-6.84 M	-6.9 M	-	-9.46 M	-6.66 M	-4.56 M	-	-4.72 M	-2.11 M	-2.07 M	-	-3.07 M	-392 K	-1.9 M	-	-1.54 M	-6.17 M	-2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	43 K	46 K	38 K	-	98 K	16 K	163 K	-	14 K	-	4 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-12.3 M	-9.86 M	-	-8.53 M	-6.41 M	-6.42 M	-	-7.44 M	-6.39 M	-6.48 M	-	-9.02 M	-6.55 M	-4.55 M	-	-4.82 M	-2.11 M	-2.09 M	-	-3.08 M	-428 K	-1.91 M	-	-1.54 M	-6.17 M	-2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	145 K	250 K	-	568 K	631 K	-	-	-	-	-	-	-	-	-8 K	-	102 K	-395	22 K	-	17.2 K	36.3 K	10 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-12.3 M	-9.86 M	-	-8.53 M	-6.41 M	-6.42 M	-	-7.44 M	-6.39 M	-6.48 M	-	-9.02 M	-6.55 M	-4.55 M	-	-4.82 M	-2.11 M	-2.09 M	-	-3.08 M	-428 K	-1.91 M	-	-1.54 M	-6.17 M	-2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	12.3 M	9.86 M	-	8.57 M	6.46 M	6.46 M	-	7.54 M	6.4 M	6.64 M	-	9.04 M	6.55 M	4.55 M	-	4.82 M	2.11 M	2.09 M	-	3.08 M	428 K	1.91 M	-	1.54 M	6.17 M	2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.22 M	2.81 M	-	2.59 M	2.31 M	2.33 M	-	2.38 M	2.22 M	2.33 M	-	2.52 M	2.09 M	2.06 M	-	2.46 M	357 K	1.3 M	-	1.92 M	1.34 M	1.3 M	-	885 K	5.89 M	2.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency